» Articles » PMID: 12368479

Pathogenic and Nonpathogenic Hantaviruses Differentially Regulate Endothelial Cell Responses

Overview
Specialty Science
Date 2002 Oct 9
PMID 12368479
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Hantaviruses cause two human diseases: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Hantaviruses infect human endothelial cells but cause little or no damage to the infected endothelium. We analyzed with Affymetrix DNA Arrays (Santa Clara, CA) the endothelial cell transcriptional responses directed by hantaviruses associated with HPS [New York-1 virus (NY-1V)], HFRS [Hantaan virus (HTNV)], or by a hantavirus not associated with human disease [Prospect Hill virus (PHV)]. Hantavirus infections induced 117 cellular genes and repressed 25 genes by >3-fold, 4 days postinfection (p.i.). Although >80% of cells were infected by each virus 1 day p.i., PHV induced or repressed 67 genes at this early time compared with three genes altered by HTNV or NY-1V. The early high-level induction of 24 IFN-stimulated genes by PHV (4- to 229-fold) represents a fundamental difference in the temporal regulation of cellular responses by pathogenic and nonpathogenic hantaviruses. Because all hantaviruses induced >23 IFN-stimulated genes at late times p.i., pathogenic hantaviruses appear to suppress early cellular IFN responses that are activated by nonpathogenic hantaviruses. At late times p.i., 13 genes were commonly induced by HTNV and NY-1V that were not induced by PHV. In contrast to NY-1V, HTNV uniquely induced a variety of chemokines and cell adhesion molecules (i.e., IL-8, IL-6, GRO-beta, ICAM), as well as two complement cascade-associated factors that may contribute to immune components of HFRS disease. NY-1V failed to induce most cellular chemokines directed by HTNV (3/14) or genes primarily activated by NF-kappaB. However, NY-1V uniquely induced beta3 integrin-linked potassium channels, which could play a role in HPS-associated vascular permeability. These studies provide a basic understanding of hantavirus-directed cellular responses that are likely to differentiate pathogenic and nonpathogenic hantaviruses, contribute to HFRS and HPS pathogenesis, and provide insight into disease mechanisms and potential therapeutic interventions.

Citing Articles

Replication kinetics of pathogenic Eurasian orthohantaviruses in human mesangial cells.

Boegelein L, Schreiber P, Philipp A, Nusshag C, Essbauer S, Zeier M Virol J. 2024; 21(1):241.

PMID: 39354507 PMC: 11446005. DOI: 10.1186/s12985-024-02517-5.


Glomerular Injury Is Associated with Severe Courses of Orthohantavirus Infection.

Nusshag C, Uhrig J, Gruber G, Schreiber P, Zeier M, Krautkramer E Pathogens. 2024; 13(8).

PMID: 39204293 PMC: 11356809. DOI: 10.3390/pathogens13080693.


A Comprehensive Analysis of Renal and Endothelium Dysfunction Markers Fourteen Years after Hemorrhagic Fever with Renal Syndrome Contraction.

Ledina D, Ivic I, Tadin A, Bodulic K, LeDuc J, Markotic A Life (Basel). 2024; 14(5).

PMID: 38792596 PMC: 11122023. DOI: 10.3390/life14050575.


Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.

Zarate-Sanchez E, George S, L Moya M, Robertson C Biofabrication. 2024; 16(3).

PMID: 38749416 PMC: 11151171. DOI: 10.1088/1758-5090/ad4c0b.


Species-specific responses during Seoul orthohantavirus infection in human and rat lung microvascular endothelial cells.

Noack D, van den Hout M, Embregts C, van IJcken W, Koopmans M, Rockx B PLoS Negl Trop Dis. 2024; 18(3):e0012074.

PMID: 38536871 PMC: 11020687. DOI: 10.1371/journal.pntd.0012074.


References
1.
Maruo N, Morita I, Shirao M, Murota S . IL-6 increases endothelial permeability in vitro. Endocrinology. 1992; 131(2):710-4. DOI: 10.1210/endo.131.2.1639018. View

2.
Hiratsuka S, Maru Y, Okada A, Seiki M, Noda T, Shibuya M . Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res. 2001; 61(3):1207-13. View

3.
Byzova T, Goldman C, Pampori N, Thomas K, Bett A, Shattil S . A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell. 2000; 6(4):851-60. View

4.
McHugh K, Tsakiris D, Rayburn H, Crowley D, Ross F, Coller B . Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999; 103(2):229-38. PMC: 407888. DOI: 10.1172/JCI5487. View

5.
Mackow E, Gavrilovskaya I . Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol. 2001; 256:91-115. DOI: 10.1007/978-3-642-56753-7_6. View